These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6290056)

  • 41. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
    Inoue Y; Nakamura T; Nakanishi H; Oishi M; Hongo F; Okihara K; Mizutani S; Kuroda J; Ukimura O
    Int J Urol; 2018 Jul; 25(7):678-683. PubMed ID: 29752743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.
    Drasga RE; Williams SD; Einhorn LH; Birch R
    Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247
    [No Abstract]   [Full Text] [Related]  

  • 44. Dose-response relationships in testicular cancer.
    Cullen MH
    Eur J Cancer; 1991; 27(7):817-8. PubMed ID: 1657076
    [No Abstract]   [Full Text] [Related]  

  • 45. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
    Lorch A; Kollmannsberger C; Hartmann JT; Metzner B; Schmidt-Wolf IG; Berdel WE; Weissinger F; Schleicher J; Egerer G; Haas A; Schirren R; Beyer J; Bokemeyer C; Rick O;
    J Clin Oncol; 2007 Jul; 25(19):2778-84. PubMed ID: 17602082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chemotherapy of malignant testicular tumors].
    Weissbach L; Jaeger N; Hartlapp JH; Boedefeld EA; Vahlensieck W
    Urologe A; 1983 Sep; 22 Suppl():310-21. PubMed ID: 6314621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
    Peckham MJ; Horwich A; Blackmore C; Hendry WF
    Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombocytopenia following high-dose chemotherapy with carboplatin, etoposide and thiotepa in patients with testicular germ cell cancer.
    Minichmayr I; Nock V; Jaehde U; Kloft C
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):74-6. PubMed ID: 23260006
    [No Abstract]   [Full Text] [Related]  

  • 49. Etoposide-induced hepatic injury: a potential complication of high-dose therapy.
    Johnson DH; Greco FA; Wolff SN
    Cancer Treat Rep; 1983 Nov; 67(11):1023-4. PubMed ID: 6315228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
    Necchi A; Pond GR; Nicolai N; Giannatempo P; Raggi D; Adra N; Hanna NH; Salvioni R; Einhorn LH; Albany C
    Clin Genitourin Cancer; 2017 Apr; 15(2):306-312.e3. PubMed ID: 27594554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
    Goldhirsch A; Joss R; Cavalli F; Brunner KW
    Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
    [No Abstract]   [Full Text] [Related]  

  • 52. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
    Harstrick A; Schmoll HJ; Wilke H; Köhne-Wömpner CH; Stahl M; Schöber C; Casper J; Bruderek L; Schmoll E; Bokemeyer C
    J Clin Oncol; 1991 Sep; 9(9):1549-55. PubMed ID: 1651992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Durable Response to Immune Checkpoint Blockade in a Platinum-Refractory Patient With Nonseminomatous Germ Cell Tumor.
    Chi EA; Schweizer MT
    Clin Genitourin Cancer; 2017 Oct; 15(5):e855-e857. PubMed ID: 28465048
    [No Abstract]   [Full Text] [Related]  

  • 54. Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors.
    Fein DE; Paulus JK; Mathew P
    JAMA Oncol; 2018 Dec; 4(12):1661-1662. PubMed ID: 30325997
    [No Abstract]   [Full Text] [Related]  

  • 55. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
    Bajorin DF; Motzer RJ; Rodriguez E; Murphy B; Bosl GJ
    J Natl Cancer Inst; 1993 Jan; 85(1):60-2. PubMed ID: 7677936
    [No Abstract]   [Full Text] [Related]  

  • 56. Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.
    Eagan RT
    Cancer Treat Rev; 1982 Jun; 9 Suppl():119-31. PubMed ID: 6889917
    [No Abstract]   [Full Text] [Related]  

  • 57. Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance.
    Al-Obaidy KI; Chovanec M; Cheng L
    Expert Rev Anticancer Ther; 2020 Feb; 20(2):75-79. PubMed ID: 31951790
    [No Abstract]   [Full Text] [Related]  

  • 58. Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.
    Levi JA; Thomson D; Harvey V; Gill G; Raghavan D; Tattersall M; Snyder R; Burns I; Sandeman T; Byrne M
    J Clin Oncol; 1990 Jan; 8(1):27-32. PubMed ID: 2153192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
    Scardino PT; Skinner DG
    Surgery; 1979 Jul; 86(1):86-93. PubMed ID: 88077
    [No Abstract]   [Full Text] [Related]  

  • 60. Cerebrovascular accident after chemotherapy for testicular cancer.
    Karagoz B; Bilgi O; Akyol I; Ozgun A; Turken O; Kandemir EG
    Mil Med; 2009 Mar; 174(3):320-1. PubMed ID: 19354100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.